OPWM
GNOM icon

Oxinas Partners Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Oxinas Partners Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,053
Closed -$137K – 126
2025
Q2 		$137K Buy
4,053
+438
+12% +$13.9K 0.07% 124
2025
Q1 		$115K Buy
3,615
+954
+36% +$36.2K 0.07% 121
2024
Q4 		$103K Buy
+2,661
New +$112K 0.06% 114

Other funds holding GNOM

FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Oxinas Partners Wealth Management's GNOM Position: Q3 2025 in Review

Oxinas Partners Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 4,053 shares — an estimated $137K sold.

Oxinas Partners Wealth Management first reported a position in GNOM in Q4 2024 and held it in 3 quarters. The position peaked at $137K in Q2 2025. 43 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

  • Oxinas Partners Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Oxinas Partners Wealth Management sold 4,053 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $137K.
  • Oxinas Partners Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and held it in 3 quarters.
  • Oxinas Partners Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $137K in Q2 2025.
  • 43 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Oxinas Partners Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.